Pure Global

"Zeiss" Asfinafil spherical hydrophilic posterior chamber intraocular lens - Taiwan Registration 2bbd9eca0815cabd402d767f4e616ce6

Access comprehensive regulatory information for "Zeiss" Asfinafil spherical hydrophilic posterior chamber intraocular lens in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 2bbd9eca0815cabd402d767f4e616ce6 and manufactured by CARL ZEISS MEDITEC AG;; Carl Zeiss Meditec SAS. The authorized representative in Taiwan is Carl Zeiss Co., Ltd. Taipei Branch.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
2bbd9eca0815cabd402d767f4e616ce6
Registration Details
Taiwan FDA Registration: 2bbd9eca0815cabd402d767f4e616ce6
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

"Zeiss" Asfinafil spherical hydrophilic posterior chamber intraocular lens
TW: โ€œ่”กๅธโ€ ่‰พๆ–ฏ่ฒ้‚ฃ้ž็ƒ้ข่ฆชๆฐดๆ€งๅพŒๆˆฟไบบๅทฅๆฐดๆ™ถ้ซ”
Risk Class 3

Registration Details

2bbd9eca0815cabd402d767f4e616ce6

DHA05603633302

Company Information

Product Details

Details are as detailed as approved Chinese instructions

M Ophthalmology

M.3600 Artificial Crystal

Contract manufacturing;; input

Dates and Status

Mar 22, 2023

Mar 22, 2028